NEWARK, New Jersey (WABC) -- Newark Mayor Ras Baraka announced Tuesday that the city is filing a lawsuit against the operators of Delaney Hall to close the detention center due to reports of health ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related cancers, namely lung, breast, colorectal, and liver cancers. In addition, GLP-1 ...

A unit about the size of an air conditioner, mounted in the side yard, could soon be humming away on artificial intelligence tasks, drawing power from your home’s energy supply and earning you ...

Florida-based AP governance firm selected as an RFP-stage contender, reinforcing its leadership in SAP vendor and customer master data compliance, modernization, and enterprise AP controls. PORT ST.

Google GOOGL1.17%increase; up pointing triangle is in talks with SpaceX for a rocket-launch deal as the search giant expands its own efforts to put orbital data centers in space, according to people ...

Erasca Inc. (NASDAQ:ERAS) is one of the best performing NASDAQ stocks according to Wall Street analysts. On April 27, Erasca announced positive preliminary Phase 1 data for ERAS-0015, a pan-RAS ...

Span, a California-based startup, has developed small, fractional data centers, or "nodes," called XFRA units. The idea is to take advantage of unused electrical capacity on local grids, which the ...

After debunking earlier rumors that it was acquiring RAS superstar Revolution Medicines, AbbVie is now taking a more definitive step into the red-hot cancer field. The Chicago pharma has agreed to ...

Gennadiy Tsygan knows how expensive it is to build a home in the United States. That’s why he imported almost everything for his dream house from China. Most of his home fixtures were imported ...

Earlier this week, Revolution Medicines reported positive results from a global Phase III trial of its RAS‑targeting inhibitor daraxonrasib (RMC-6236) in metastatic pancreatic ductal adenocarcinoma ...

WASHINGTON, March 25 (Reuters) - U.S. import prices increased by the most in four years in February as energy costs surged in anticipation of conflict in the Middle East, adding to signs that ...